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Abstract
Adrenalectomy is the most appropriate treatment for unilateral adrenal tumors. This study aimed at describing the 
epidemiological characteristics and perioperative behavior of canine patients submitted to adrenalectomy at Anhembi 
Morumbi Veterinary Hospital. Out of 13 dogs, eight were pure breeds and five were mixed breeds; 12 females, aged 
9.5 ± 2.5 years old. Regarding the tumors, seven were located on the right and histopathological analysis revealed cortical 
adenoma in 11 and adenocarcinoma in only two dogs. Two cases had hypercortisolism recurrence associated with hyperplasia 
in the contralateral adrenal, as confirmed by ACTH stimulation test. The results of this study indicate that adrenalectomy 
is a safe procedure with few perioperative complications, despite the possibility of hypercortisolism recurrence.
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Resumo
Adrenalectomia é o tratamento mais indicado para neoplasias adrenais unilaterais. Objetivou-se descrever os aspectos 
epidemiológicos e o comportamento perioperatório em cães submetidos a adrenalectomia no Hospital Veterinário Anhembi 
Morumbi. Dos 13 casos, oito eram cães de raças puras e cinco eram SRD; 12 eram fêmeas e de idade de 9,5 ± 2,5 anos. 
Das massas adrenais, sete eram em lado direito. Os exames histopatológicos revelaram adenoma cortical em 11 cães e 
adenocarcinoma em dois. Dois casos recidivaram a condição de hipercortisolemia, associada à hiperplasia, na adrenal 
contralateral, confirmados pelo teste de estimulação por ACTH. Concluiu-se que a adrenalectomia é um procedimento 
seguro, com poucas complicações perioperatórias, ressalvando-se a possiblidade de recidiva do quadro de hipercortisolismo.
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Primary adrenal neoplasms are not rare and are 
the cause of hypercortisolemia in 10% to 20% of the 
cases overall (DAVIS et al., 2012). The most commonly 
found primary adrenal tumors are adenomas and 
adenocarcinomas, followed by pheochromocytoma 
and others, which are the minority (FELDMAN, 2008; 
FRANKOT et al., 2012).
A reliable and accurate diagnosis of the adrenal 
neoformation requires careful clinical monitoring and 
laboratory tests, which must include blood pressure, 
complete blood count, complete urinalysis (with microbial 
culture) and serum biochemical profile. Specific tests of 
adrenal function, such as measurement of urinary steroids 
(urinary cortisol/creatinine ratio), cortisol before and after 
ACTH stimulation test and suppression test with low-
dose dexamethasone are also required (CAPEN, 2007; 
FELDMAN, 2008; NELSON, 2010).
Endogenous ACTH concentration test is 
also recommended to differentiate the origin of 
hypercortisolemia, as it may be (adrenocorticotropic) 
primary or (pituitary) ACTH-dependent (NELSON, 
2010; BEHREND et al., 2013). Its measurement is a 
good indication source when hypercortisolism diagnosis 
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has already been established. Endogenous ACTH 
levels tend to be normal to elevated in cases of ACTH-
dependent hypercortisolism and are generally low or 
undetectable in dogs with adrenal tumors or iatrogenic 
hyperadrenocorticism (SCHIMMER; PARKER, 2007; 
BRÖMEL et al., 2013). The reference values vary depending 
on the technique used; thus, they vary between the levels 
established by each laboratory (BEHREND et al., 2013).
Abdominal ultrasound is initially used to assess the 
adrenal gland to evaluate the size and symmetry of the glands; 
in visualization, measurement and echogenicity of tumor 
masses and, finally, for an overall scanning of the abdomen, 
especially areas adjacent to the adrenals to investigate the 
presence of possible metastasis. If the abdominal ultrasound 
confirms the presence of a mass in the adrenal topography, 
plain and contrasted abdominal CT scans are necessary. 
Chest x-rays should be evaluated for evidence of pulmonary 
metastasis of an adrenocortical carcinoma (CAPEN, 2007; 
NELSON, 2010). Computed tomography and magnetic 
resonance imaging disclose the presence of pituitary tumors 
larger than 1 cm and these are the most accurate tests for 
investigating the source of hypercortisolism and obtaining 
images of the adrenal gland (BEHREND et al., 2013).
Currently, adrenalectomy is the treatment of choice for 
unilateral adrenal tumors (PELÁEZ et al., 2008; NELSON, 
2010; LANG et al., 2011). However, adrenalectomy is 
associated with a high rate of perioperative mortality 
in dogs (SCHWARTZ et al., 2008). On the other hand, 
Massari et al. (2011) found a mean survival time greater 
than 10 months, postoperatively.
Reported complications associated with adrenalectomy 
in dogs include fluid and electrolyte imbalances, post-
surgical adrenal gland failure, bleeding, hypotension, 
arrhythmias, pulmonary thromboembolism, disseminated 
intravascular coagulation, pancreatitis and acute renal 
failure. Wound infection and dehiscence may be observed, 
due to the negative effects of steroids on wound healing 
(LANG et al., 2011; BARRERA et al., 2013; FOSSUM, 2013).
It has been generally accepted that the long-term 
prognosis of post-adrenalectomy is favorable, considering 
that the animal survived the perioperative period. 
Identifying the factors that currently influence the 
perioperative mortality can be useful to guide treatment 
recommendations (LANG et al., 2011).
Other important factors to consider are tumor relapse 
cases, as well as adrenal hyperfunction after adrenalectomy, 
but there are a few specific studies on the subject. Related to 
adrenalectomy in dogs with hyperadrenocorticism caused 
by adrenocortical tumors, Van Sluijs et al. (1995) reported 
a small but substantial hypercortisolemia recurrence 
development index after adrenalectomy, confirmed 
by measuring urinary cortisol or cortisol suppression 
by dexamethasone. Moreover, there is the possibility 
of occurrence of metastases, which also result in the 
recurrence of the clinical state (LANG et al., 2011).
Objectives
Based on the data raised, particularly regarding the scarce 
information on the subject, this project aimed to describe the 
epidemiological characteristics and perioperative behavior 
of dogs submitted to adrenalectomy at Anhembi Morumbi 
Veterinary Hospital (HOVET), from January 2012 to July 
2015. Project goals included determining which major 
complications were observed in these patients, the current 
health status of the animals, as well as assessing the incidence 
of adrenal hyperfunction recurrence, treatment employed 
and the animals’ individual response to treatment, with the 
objective of aiding development of adequate prognosis when 
adrenalectomy was indicated as treatment protocol.
Methods
A retrospective quantitative descriptive study (January 
2012 to July 2015) was carried out by evaluating records 
of patients submitted to the surgical procedure of 
adrenalectomy at HOVET to analyze and collect the data. 
Owners of animals submitted to the procedure without 
regular or recent appointments at Anhembi Morumbi 
HOVET were contacted by telephone to determine the 
animal’s current health status. During the retrospective 
search, the following were documented: patient species, 
breed, age, gender, diagnosis and pre-surgical management; 
surgical outcomes; results of histopathological exam; 
assessment of the current health status of the animals and 
how many of these animals had shown contralateral or 
pituitary-dependent hyperadrenocorticism recurrence 
after the adrenalectomy, as well as how long it took the 
animal to have this recurrence, protocols employed for the 
diagnosis and treatment of the condition.
Development and Results
A retrospective quantitative descriptive study was 
carried out through analysis of the medical records of 
patients submitted to adrenalectomy. Telephone contact 
was made with 13 owners to update the medical history 
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and investigate the animals’ current health status. Data 
were collected in a spreadsheet to be analyzed.
Of the 13 animals, eight were of pure breeds – Lhasa 
Apso (two), Shih-Tzu (two), English Cocker Spaniel (one), 
Labrador Retriever (one), Maltese (one) and Poodle (one) 
– and five were mixed-breed; 12 were females. Mean age 
was 9.5 ± 2.5 years. Mean body weight was 22.1 ± 18.5 kg 
(Table 1).
Table 1 –  General characteristics of dogs that underwent adrenalectomy at the Anhembi Morumbi Veterinary Hospital – São Paulo, 
Brazil – 2012-2015
Dog Signalment Signs Affected Adrenal
Preview 
Treatment
1 Mixed Breed; 9 years; female; 19 kg polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Right Trilostane
2 Poodle 11 years; female; 7.5 kg polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Left Mitotane
3 Mixed Breed; 8 years; female; 5 kg polyphagia; polydipsia Left X
4 Mixed Breed; 11 years; female; 15.4 kg polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Left X
5 Cocker Spaniel; 12 years; male; 19.5 
kg
polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Left Trilostane
6 Lhasa Apso; 12 years; female; 4.2 kg polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Right Trilostane
7 Labrador; 12 years; female; 31.6 kg polyphagia; polydipsia; polyuria; bulging abdomen Left X
8 Mixed Breed; 11 years; female; 40.6 kg No signs reported Left X
9 Lhasa Apso; 9 years; female; 11.2 kg polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Right X
10 Shih-Tzu; 9 years; female; 8.7 kg polyphagia; polydipsia; polyuria; bulging abdomen; 
telangiectasia
Right Trilostane
11 Shih-Tzu; 8 years; female; 7.6 kg polyphagia; polydipsia Right Trilostane
12 Mixed Breed; 10 years; female; 10.5 kg polyphagia; polydipsia; polyuria Right Trilostane
13 Maltês; 7 years; female; 3.6 kg polyphagia; polydipsia; polyuria Right X
The main clinical signs observed at the animals’ clinical 
presentation related to the diagnosis of hypercortisolism 
were polyuria and polydipsia (12), polyphagia (10), 
bulging abdomen (eight) and telangiectasia (seven), 
as shown in table 1. At the laboratory tests, a complete 
blood count showed thrombocytosis in four animals, 
with values ranging from 556.000 to 670.000 platelets/µL. 
The biochemical tests showed great levels of AP in eight 
dogs (176-8099 U.I./L), ALT in seven dogs (106-520 U.I./L), 
hypertriglyceridemia in eight of the dogs (102-357.6 mg/dL) 
and hypercholesterolemia in seven dogs (288-393 mg/dL). 
Systemic arterial hypertension was observed in four dogs 
(Systolic Blood Pressure: 160-213 mmHg, monitored 
indirectly by Doppler system.). Only seven of the 13 animals 
had urinalysis performed and of these, four animals had 
specific urinary gravity within reference parameters and 
three had decreased gravity, ranging from 1.012 to 1.018.
At the preoperative assessment, alterations found in 
the echocardiography were mild to moderate mitral valve 
regurgitation (four) and significant mitral and tricuspid 
valve regurgitation (one). ECG revealed ventricular 
repolarization disorder in one dog. Other nonpathological 
alterations found were sinus arrhythmia with pacemaker 
migration (two), and sinus arrhythmia (one).
The imaging assessment of the affected adrenal glands 
showed that, seven were on the right and six on the left 
side (Table 1). It was also observed a prevalence of an 
increase in the gland caudal pole thickness. Eight of the 
13 patients underwent CT scan and one was referred to 
MRI. All nine animals showed heterogeneous contrast 
medium enhancement (ranging from moderate, marked 
or intense), with no significant difference between mass 
benignity and malignancy.
Of the 13 animals, six had previously been treated with 
trilostane, with doses of 1.1 mg/kg ± 0.4 every 12 hours 
(five) and once daily (one); one animal received previous 
treatment with mitotane at a dose of 25 mg/kg every 
12 hours (Table 1).
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All adrenalectomies were performed using the open 
ventral midline laparotomy technique; one animal had 
an additional paracostal incision, to extend the access 
area. One animal had tumor invasion of the inferior vena 
cava wall and one dog had the adrenal gland adhered 
to the renal artery; both were successfully submitted to 
gland resection, with no occurrence of bleeding. Of the 
13 animals, six had other procedures performed at the same 
surgery: cholecystectomy (one), liver biopsy in the left lobe 
and excisional biopsy of a node in the right lower eyelid 
(one), excisional biopsy of lymph node near the left adrenal 
gland (one), cauterization of a wart on the right pelvic limb 
(one), partial lobectomy of the left lateral liver lobe (one), 
excisional nodule biopsy in the right thoracic breast (one).
Regarding the transoperative complications (Figure 1), 
hypotension was observed in three dogs, one case with 
mild episodes of bradycardia, compensatory hypotension 
and sporadic ventricular escape at the electrocardiogram, 
but no pharmacological intervention was required; a 
case of hypotension unresponsive to increased fluid rate 
or atropine and reversed with continuous infusion of 
dopamine; a case of hypotension initially reversed with 
an increase in the fluid infusion rate to 20 mL/kg/hour, and 
subsequently reversed by continuous infusion of dopamine. 
The other transoperative complications observed were 
hypertension (one), hyperglycemia (one) and adrenal gland 
rupture during resection with leakage of large amounts 
of necrotic material in the cavity (one). One animal had 
seizures in the immediate postoperative period with loss of 
motor coordination; however, the seizures did not require 
pharmacological intervention.
All animals were admitted for post-surgical care, most 
of them remaining for a maximum period of 72 hours. 
During this period, all of them received prednisone 
(0.6 ± 0.4 mg/kg) for 3 to 7 days, as well as antibiotics 
and analgesia. None of the dogs presented hypofunction 
or failure of the contralateral adrenal gland verified 
by the general state of the dogs and follow up serum 
cortisol analysis.
The main complaints during subsequent consultations 
post-adrenalectomy (Figure 2) were persistence of polyuria 
and polydipsia (10), hyporexia (seven) and vomiting (four). 
Two cases had reaction to the suture – one mild case in 
the first postoperative month, which did not require drug 
intervention and one case with fistulae for a few months’ 
post-adrenalectomy, which was treated with antibiotic 
therapy. One animal died 23 days after the surgery due to 
necrosis of the incision and surrounding tissue, followed 
by abdominal evisceration.
Histopathological analysis showed adrenal gland 
cortical adenoma in eleven dogs and adrenal gland cortical 
adenocarcinoma in only two of the investigated cases. Both 
were large females (Labrador Retriever and mixed-breed), 
aged 11 and 12 years, and with masses located in the left 
adrenal gland. One case had a previous diagnosis of 
hyperadrenocorticism, with moderate clinical symptoms 
and treatment with trilostane. The second case had the 
adrenal tumor identified at tests requested by emergency 
care after a syncope; the animal showed no obvious clinical 
signs of hyperadrenocorticism. The owners of both dogs 
denied any clinical signs related to hyperadrenocorticism 









Figure 1 –  Peri and transoperative complications documented in 13 assessed cases of adrenalectomy performed in dogs at the 













Figure 2 –  Post-adrenalectomy complaints observed in dogs during the first three postoperative follow up consultations at the 
Anhembi Morumbi Veterinary Hospital (2012-2015)
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Four of the 13 dogs had endogenous ACTH measured 
before admission to surgery, two of the animals had results 
below the levels considered normal by the laboratory 
reference values (8 and 8.9 pg/mL), suggesting adrenal 
gland tumor, and two had values within the normal range 
(15.3 and 38.3 pn/mL). Histopathological test results of the 
four animals showed adrenal cortical adenoma and none 
of these has had symptoms related to recurrence to date.
Of the 13 cases analyzed, two had hypercortisolism 
recurrence associated with hyperplasia in the contralateral 
adrenal (both cases in the right adrenal), five to 
11  months’ post-adrenalectomy, as demonstrated by 
the symptoms and the ACTH stimulation test. Both are 
currently being treated with trilostane to control the disease.
Discussion
During the investigation of the 13 cases involved in 
this study, the highest incidence of hypercortisolemia with 
neoformation was found in adrenal gland of females (11), as 
was also ascertained by Massari et al. (2011). On the other 
hand, Lang et al. (2011), Naan et al. (2013) and Andrade et 
al. (2014) showed a very similar incidence between males 
and females (55.5% females). The ascertained breeds, there 
was a heterogeneous representation in the group, noting 
that Labradors were reported by Schwartz et al. (2008), Lang 
et al. (2011), Massari et al. (2011), Naan et al. (2013) and 
Andrade et al. (2014), followed by Shih-Tzus – Schwartz 
et al. (2008), Lang et al. (2011) and Massari et al. (2011). 
Throughout the literature, the condition has been reported 
to also occur in mixed breed’s dogs (PELÁEZ et al., 2008; 
LANG et al., 2011; MASSARI et al., 2011; BARRERA et al., 
2013; NAAN et al., 2013).
The main clinical alterations noted prior to the 
adrenalectomy do not differ from the literature. The main 
ones are polyuria and polydipsia, polyphagia and bulging 
abdomen. Biochemical analysis shows an increase in 
the levels of PA, ALT, triglycerides and cholesterol. Such 
changes are also reported by Peláez, Bouvy and Dupré 
(2008), Lang et al. (2011) and Andrade et al. (2014).
In imaging, as far as the side of the occurrence of the 
masses, Peláez et al. (2008) have evidenced four in left adrenal 
and three on the right. In 2011, Lang et al. reported in their 
study 32 on the left side and 29 on the right. In turn, Massari 
et al. (2011) reported 25 (48%) in the right adrenal gland and 
16 (30.8%) at the left. This research presents seven masses on 
the right side and six on the left; therefore, not demonstrating 
a greater trend incidence in one of the adrenal glands.
Regarding the intraoperative complications, the most 
frequently observed is hypotension (LANG et al., 2011; 
MASSARI et al., 2011; BARRERA et al., 2013; ANDRADE 
et al., 2014). Three cases of hypotension were observed 
in this study, one of them along with bradycardia and 
compensatory ventricular escape. Hypotension is the most 
common anesthetic complication observed in patients and 
its pathogenesis can be multifactorial. It is often an adverse 
pharmacological effect of many sedatives, analgesics and 
anesthetics (intravenous and inhaled) which directly affect 
the heart rate, preload, afterload, myocardial contractility 
and / or systemic vascular resistance. These variables 
are closely associated with blood pressure; therefore, a 
change in either (alone or in combination) may affect 
blood pressure. Moreover, age, concomitant diseases and 
duration of anesthesia may predispose patients to present 
hypotension (IIZUKA et al., 2013; RUFFATO et al., 2015).
The other intraoperative complications observed are 
one case of hypertension, as also reported by Barrera et 
al. in 2013, which found 12 cases of hypertension of 86 
investigated; adrenal gland rupture during resection with 
extravasation of large amounts of necrotic material into 
the cavity (one). One animal had seizures in the immediate 
postoperative period with loss of motor coordination, 
but it was an isolated episode and there was no need for 
pharmacological intervention.
Some well-known complications can be related to the 
hypofunction of the remaining adrenal gland, what can lead 
to an adrenal insufficiency crisis. This can be prevented with 
glucocorticoid supplementation using various protocols in 
the perioperative period described in all published studies 
(KYLES et al., 2003; PELÁEZ et al., 2008; MASSARI et al., 
2011; LANG et al., 2011; NAAN et al., 2013). Peláez (2008), 
Massari et al. (2011) and Naan et al. (2013) all administered 
dexamethasone and the dosage varied from 0.05-1 mg/kg, 
while Lang et al. (2011) administered hydrocortisone 
acetate 2 mg/kg/IV or dexamethasone (0.07 mg/kg IV) 
immediately after anesthetic induction. Massari et al. 
(2011), Lang et al. (2011) and Naan et al. (2013) described 
the administration of prednisone 1 mg/kg PO SID or 
BID with the dosage tapered and discontinued between 
4 and 12 weeks. Peláez et al. (2008) chose to administer 
prednisolone 0.2 mg/kg PO BID with the dosage tapered 
and discontinued over  4-6 weeks. There was no referral of 
adrenal hypofunction on any of the researches.
Fossum (2013) suggested that glucocorticoid 
therapy should start before surgery in patients 
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with hipercortisolemia which are undergoing 
adrenalectomy and described the therapy being 
possible with the administration of dexamethasone 
(0.1-0.2 mg/kg), Hydrocortisone Hemisuccinate (2 mg/
kg) or Hydrocortisone Phosphate (2 mg/kg) 1 hour 
before surgery. Fossum also suggests as postoperative 
glucocorticoid supplementation protocol the 
administration of Dexamethasone (0,01-0,1 mg/kg IV or 
SC q 6-8 hrs for 1-3 days and then begin with prednisolone 
(0,5 mg/kg q 12 hrs for 2-3 days, then slowly decrease the 
dose every 3 weeks to the lowest tolerated dose.
Wise and Boveri (2016) stated on his case review 
that, as commonly occurs, it was unknown if the 
remaining hypoplastic adrenal gland would be capable 
of producing sufficient glucocorticoid and one single 
postoperative dose of prednisolone was administered 
to provide supplementation for the recovery from the 
physiological stress caused by anesthesia and surgery. 
Close monitoring of the patient showed no signs of 
hypoadrenocorticism crises.
At the present study, two of the patients received 
5 mg/kg bolus of hydrocortisone acetate right before 
submitting to the surgery; one dog received the 5 mg/kg 
bolus and was also put under hydrocortisone acetate 
CRI (5 mg/kg/H). One patient did not receive the bolus 
application and was placed on hydrocortisone acetate 
CRI on a 5 mg/kg/H rate. There was no complication found 
tied to receiving a source of corticoid supplementation 
pre or trans operative when compared to the 9 patients 
that did not receive any.
All patients at the present study received prednisone 
(0.6 ± 0.4 mg/kg, PO, q 24 hr) for only 3 to 7 days, starting 
at the surgery´s next day. None of the dogs presented 
hypofunction or failure of the contralateral adrenal gland 
verified by the general state of the dogs and follow up 
serum cortisol analysis.
The main complaints in the post-surgical rechecks were 
persistence of polyuria and polydipsia (10) observed up to 
the current level of circulating glucocorticoids decrease 
sufficiently so that it no longer impacts glomerular 
filtration rate and renal tubular reabsorption of water 
and also the action of antidiuretic hormone (ADH) is 
regularized. Schwartz et al. (2008) also observed this 
clinical alteration and reported an average persistence of 
up to 71 days after adrenalectomy. In 2008, Peláez et al. 
have also reported persistence of polyuria, polydipsia and 
polyphagia for up to four weeks after adrenalectomy. The 
present study found that four of the 13 animals presented 
persistent polyphagia over the postsurgical appointments 
(22 ± 7 days). Another alteration commonly seen in 
adrenalectomy post-surgery is emesis, as also quoted by 
Barrera et al. (2013) and Lang et al. (2011), four of the dogs 
within this study presented emesis during the few first 
days after the procedure. The hyporexia also presented 
may be related to pain and discomfort during the first few 
days after surgery, and is not mentioned by any author as 
a relevant effect.
Like evidenced Schwartz et al. (2008), Lang et al. (2011) 
and Massari et al. (2011), the results of the histopathological 
analysis in this study demonstrate the prevalence of adrenal 
cortical adenoma found in 11 dogs, followed by only two 
cases of adenocarcinomas. On the other hand, Barrera et 
al. (2013) reported that out of 86 cases analyzed during 
their study, 45 were adrenocortical adenocarcinoma and 
only 14 cases were adrenocortical adenoma.
Adrenalectomy is the main therapeutic indication for 
the hyperadrenocorticism cases ACTH non-dependent 
and related to primary adrenal neoplasms. The main 
expectation regarding the procedure, when successful, 
is curing the condition of hypercortisolemia. However, 
recurrence of contralateral adrenal hyperfunction after 
a certain period is a fact already observed in a very few 
studies. A research by Van Sluijs et al. (1995) suggested 
the incidence of hypercortisolemia recurrence months 
after having the adrenalectomy performed. Of the 
26 dogs in the study that underwent adrenalectomy, 
eight had hyperfunction recurrence by the contralateral 
adrenal confirmed. The same fact was also observed 
by Lang et al. (2011), who reported an occurrence of 
12% of 60  cases analyzed developing recurrence of the 
condition. In the present study, two dogs had recurrence 
of the hypercortisolemia associated with contralateral 
adrenal hyperplasia (both right sided), 5 and 11 months’ 
post-adrenalectomy. Only one dog underwent CT 
during the investigation of its case, with the images 
suggestive of adrenal tumor. None of them had ACTH-
endogenous analysis before surgery and only one was 
submitted to the dexamethasone suppression test, 
highlighting the need for a more thorough investigation 
when it comes to additional complementary tests for the 
ideal candidates’ selection when adrenalectomy is the 
treatment of choice.
Adrenalectomy is generically associated with a high 
perioperative mortality rate in dogs (SCHWARTZ et al., 
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2008; LANG et al., 2011). However, the present study 
revealed the death of only one of the 13 dogs directly 
related to the procedure and during postoperative period. 
Massari et al. (2011) states that dogs that survive the 
postoperative period reach, in most cases, good results 
with average survival time greater than 10 months. Of 
the remaining 12 animals in the present study, one death 
was found 27 months after the adrenalectomy due to 
unrelated reasons. Nine of the animals are currently 
healthy in general, with the longest post-adrenalectomy 
survival period found to date of three years. The two dogs 
with recurrent hypercortisolemia condition are currently 
being treated with trilostane to control the condition and 
post-adrenalectomy mean survival period for both are 
2.6 years ± 6 months until the study’s conclusion.
Final considerations
Adrenalectomy can be considered a safe procedure, 
with few trans and postoperative complications, apart 
from the possibility of hypercortisolism recurrence. 
This situation can be prevented by previous additional 
complementary tests.
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